成人起病1型糖尿病中胰岛自身抗体状态与1型糖尿病遗传风险的关系
研究比较了1814例临床诊断1型糖尿病患者(1112例成人起病,702例儿童起病)的1型糖尿病遗传风险评分与自身抗体状态。成人起病自身抗体阴性者遗传风险低于阳性者但高于2型糖尿病,调整估算的非自身免疫糖尿病后,成人起病自身抗体阳性率与儿童相似(93% vs 91%,p=0.4),提示误分类的非自身免疫糖尿病是成人起病1型糖尿病自身抗体阳性率较低的最可能原因。
要点
- 儿童起病1型糖尿病中自身抗体阴性与阳性者遗传风险相似(p=0.4)。
- 成人起病自身抗体阴性者遗传风险低于阳性者(p<0.0001)但高于2型糖尿病(p<0.0001)。
- 调整估算的非自身免疫糖尿病后,成人起病1型糖尿病自身抗体阳性率与儿童相似(93% vs 91%,p=0.4)。
核心结论
- 非自身免疫糖尿病的纳入是临床诊断成人起病1型糖尿病中观察到的自身抗体阳性率较低的最可能解释。
- 数据支持在常规临床实践中对临床疑似成人起病1型糖尿病进行胰岛自身抗体检测的实用性。
研究设计与样本
- 分析了1814例临床诊断1型糖尿病患者(1112例成人起病,702例儿童起病)诊断时的GAD自身抗体、胰岛素瘤2抗原自身抗体和锌转运体8自身抗体(ZnT8A),并对30个1型糖尿病相关变异进行基因分型以计算1型糖尿病遗传风险评分(T1DGRS)。
- 比较了成人起病和儿童起病糖尿病中自身抗体状态与总体T1DGRS及非HLA和HLA(DR3-DQ2、DR4-DQ8和DR15-DQ6)成分的关系。
- 从Wellcome Trust病例对照联盟纳入1924例2型糖尿病患者作为非自身免疫糖尿病对照,测量其T1DGRS。
主要发现
- 临床诊断儿童起病1型糖尿病中,自身抗体阴性与阳性者的T1DGRS相似(均值[SD] 0.274 [0.034] vs 0.277 [0.026],p=0.4)。
- 成人起病1型糖尿病中,自身抗体阴性者的T1DGRS低于自身抗体阳性者(均值[SD] 0.243 [0.036] vs 0.271 [0.026],p<0.0001),但高于2型糖尿病(均值[SD] 0.229 [0.034],p<0.0001)。
- 自身抗体阴性成人较自身抗体阳性成人更可能携带保护性HLA DR15-DQ6基因型(15% vs 3%,p<0.0001),更不可能携带高风险HLA DR3-DQ2/DR4-DQ8基因型(6% vs 19%,p<0.0001),且非HLA T1DGRS更低(p<0.0001)。
- 与儿童相反,自身抗体阴性成人较自身抗体阳性成人更可能为男性(75% vs 59%)、BMI更高(27 vs 24 kg/m2)且更少合并其他自身免疫病(2% vs 10%)(所有p<0.0001)。
- 在成人和儿童中,1型糖尿病遗传风险均不受自身抗体数量的影响(p>0.3)。
临床怎么用
- 作者认为数据支持在常规临床实践中对临床疑似成人起病1型糖尿病进行胰岛自身抗体检测的实用性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The reason for the observed lower rate of islet autoantibody positivity in clinician-diagnosed adult-onset vs childhood-onset type 1 diabetes is not known. We aimed to explore this by assessing the genetic risk of type 1 diabetes in autoantibody-negative and -positive children and adults. METHODS: We analysed GAD autoantibodies, insulinoma-2 antigen autoantibodies and zinc transporter-8 autoantibodies (ZnT8A) and measured type 1 diabetes genetic risk by genotyping 30 type 1 diabetes-associated variants at diagnosis in 1814 individuals with clinician-diagnosed type 1 diabetes (1112 adult-onset, 702 childhood-onset). We compared the overall type 1 diabetes genetic risk score (T1DGRS) and non-HLA and HLA (DR3-DQ2, DR4-DQ8 and DR15-DQ6) components with autoantibody status in those with adult-onset and childhood-onset diabetes. We also measured the T1DGRS in 1924 individuals with type 2 diabetes from the Wellcome Trust Case Control Consortium to represent non-autoimmune diabetes control participants. RESULTS: The T1DGRS was similar in autoantibody-negative and autoantibody-positive clinician-diagnosed childhood-onset type 1 diabetes (mean [SD] 0.274 [0.034] vs 0.277 [0.026], p=0.4). In contrast, the T1DGRS in autoantibody-negative adult-onset type 1 diabetes was lower than that in autoantibody-positive adult-onset type 1 diabetes (mean [SD] 0.243 [0.036] vs 0.271 [0.026], p<0.0001) but higher than that in type 2 diabetes (mean [SD] 0.229 [0.034], p<0.0001). Autoantibody-negative adults were more likely to have the more protective HLA DR15-DQ6 genotype (15% vs 3%, p<0.0001), were less likely to have the high-risk HLA DR3-DQ2/DR4-DQ8 genotype (6% vs 19%, p<0.0001) and had a lower non-HLA T1DGRS (p<0.0001) than autoantibody-positive adults. In contrast to children, autoantibody-negative adults were more likely to be male (75% vs 59%), had a higher BMI (27 vs 24 kg/m2) and were less likely to have other autoimmune conditions (2% vs 10%) than autoantibody-positive adults (all p<0.0001). In both adults and children, type 1 diabetes genetic risk was unaffected by the number of autoantibodies (p>0.3). These findings, along with the identification of seven misclassified adults with monogenic diabetes among autoantibody-negative adults and the results of a sensitivity analysis with and without measurement of ZnT8A, suggest that the intermediate type 1 diabetes genetic risk in autoantibody-negative adults is more likely to be explained by the inclusion of misclassified non-autoimmune diabetes (estimated to represent 67% of all antibody-negative adults, 95% CI 61%, 73%) than by the presence of unmeasured autoantibodies or by a discrete form of diabetes. When these estimated individuals with non-autoimmune diabetes were adjusted for, the prevalence of autoantibody positivity in adult-onset type 1 diabetes was similar to that in children (93% vs 91%, p=0.4). CONCLUSIONS/INTERPRETATION: The inclusion of non-autoimmune diabetes is the most likely explanation for the observed lower rate of autoantibody positivity in clinician-diagnosed adult-onset type 1 diabetes. Our data support the utility of islet autoantibody measurement in clinician-suspected adult-onset type 1 diabetes in routine clinical practice.
引用
- Thomas NJ, Walkey HC, Kaur A, et al. The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes. Diabetologia. 2022. PMID: 36355183. doi:10.1007/s00125-022-05823-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。